Title: Health Science Executive
Location: Columbia, Maryland, United States
Raouf Guirguis, Health Science Executive, has been recognized by Marquis Who’s Who Top Executives for dedication, achievements, and leadership in medical advancements and science.
Dr. Guirguis is trusted as the leader for a number of companies and is known for making a difference with these roles. He is the owner of AiSimTech LLC, Global Preparedness International LLC, Learning Touch LLC, Fingerprint Biotech, LLC, Advanced Language Systems International LLC, Lamina Equities Corp., Diplomatic Language Services LLC, Point of Care Techs., Inc. and Biotech Pharma, LLC. He also serves as the chairman for the Cancer Diagnostics Holding Co. Prior to taking on these roles and responsibilities; he has held different executive leadership roles with MonoGen, Inc., Cancer Diagnostics, Inc. and Antibody Resources Inc. He has also been a pathology fellow of the National Institutes of Health, a research associate with the Lombardi Cancer Center and a Navy Captain with the Alexandria University School of Medicine.
Prior to these positions, Dr. Guirguis pursued an ambitious and rewarding education. He earned an MD from the University of Alexandria, as well as an MD from the institution. After relocating to the United States, he earned an MS and PhD from Georgetown University. In addition to his executive roles, he has consulted for the Nephrology Cancer Center in Egypt and taught as an adjunct professor in the department of physiology and biophysics from Georgetown University Medical School.
Dr. Guirguis is credited with many achievements in the field of health and medicine. He holds patents for such things as a CDI Shuttle System, a cancer screening and laboratory testing device. He has patents pending for an Intact and Isolated Pseudopodia Fragments, patents pending for a Model System for Cell Migration, patents pending for a Possible Role for Membrane Fusion in Tumor Cell Invasion and Metastasis and patents pending for a New Method and Device for the Early Detection of Cancer Using Body Fluids, mainly urine. He has developed a cell chamber for chemotaxis assay and a modular multiple fluid sample preparation assembly amidst other inventions and discoveries. From 1986 to 1988, he was a Saudi Minister of Health Scholar. He has also received grants from the National Council of Churches and the Hoffman-LaRoche Innovation. He is a scholar with Georgetown University and the Foreign Council.
Contact Dr. Guirguis